| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.25 | 6e-06 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.18 | 0.003 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.11 | 0.06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.084 | 0.2 |